Fate Therapeutics Inc (NASDAQ:FATE)

Delayed Data
As of May 26
 +0.095 / +1.88%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 19 analysts offering 12-month price forecasts for Fate Therapeutics Inc have a median target of 7.00, with a high estimate of 16.00 and a low estimate of 4.00. The median estimate represents a +36.32% increase from the last price of 5.14.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Hold stock in Fate Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -208.24%
Growthannually 36.03%


Growthquarterly -90.27%
Growthannually -28.72%
Key to the earnings and sales forecast charts.